US 12029782
MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof
granted A61KA61K2039/577A61K2039/605
Quick answer
US patent 12029782 (MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof) held by Cue Biopharma, Inc. expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cue Biopharma, Inc.
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/577, A61K2039/605, A61K2039/645, A61K39/0008